Seaport Therapeutics, Inc. (SPTX)
NASDAQ: SPTX · Real-Time Price · USD
20.46
+0.14 (0.69%)
At close: Jul 31, 2026, 4:00 PM EDT
20.40
-0.06 (-0.29%)
After-hours: Jul 31, 2026, 7:34 PM EDT
Seaport Therapeutics Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Seaport Therapeutics stock has a consensus rating of "Buy" and an average price target of $38. The average 1-year stock price forecast is 85.73% higher than the current stock price, while the lowest is $30 (+46.63%) and the highest is $50 (+144.38%).
Price Target: $38 (+85.73%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Seaport Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|
| Strong Buy | 3 | 3 | 4 |
| Buy | 1 | 1 | 1 |
| Hold | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 4 | 4 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Initiates $50 | Buy | Initiates | $50 | +144.38% | Jul 15, 2026 |
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Jul 7, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $30 | Buy | Reiterates | $30 | +46.63% | Jun 9, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $42 | Buy | Reiterates | $42 | +105.28% | Jun 9, 2026 |
| Citi | Citi | Buy Reiterates $35 | Buy | Reiterates | $35 | +71.07% | Jun 9, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-5.11
EPS Next Year
-2.47
from -5.11
EPS and Forward PE are based on non-GAAP adjusted numbers.